Catyalyst Pharma (CPRX) Tops Q2 EPS by 2c

August 9, 2016 4:29 PM EDT
Get Alerts CPRX Hot Sheet
Trade CPRX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment